Cargando…
The ascidian natural product eusynstyelamide B is a novel topoisomerase II poison that induces DNA damage and growth arrest in prostate and breast cancer cells
As part of an anti-cancer natural product drug discovery program, we recently identified eusynstyelamide B (EB), which displayed cytotoxicity against MDA-MB-231 breast cancer cells (IC(50) = 5 μM) and induced apoptosis. Here, we investigated the mechanism of action of EB in cancer cell lines of the...
Autores principales: | Liberio, Michelle S., Sadowski, Martin C., Davis, Rohan A., Rockstroh, Anja, Vasireddy, Raj, Lehman, Melanie L., Nelson, Colleen C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791278/ https://www.ncbi.nlm.nih.gov/pubmed/26733491 |
Ejemplares similares
-
Identification of Eusynstyelamide B as a Potent Cell Cycle Inhibitor Following the Generation and Screening of an Ascidian-Derived Extract Library Using a Real Time Cell Analyzer
por: Liberio, Michelle S., et al.
Publicado: (2014) -
Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells
por: Levrier, Claire, et al.
Publicado: (2017) -
Differential Effects of Tissue Culture Coating Substrates on Prostate Cancer Cell Adherence, Morphology and Behavior
por: Liberio, Michelle S., et al.
Publicado: (2014) -
Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment
por: Sieh, Shirly, et al.
Publicado: (2012) -
Correction: Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment
por: Sieh, Shirly, et al.
Publicado: (2013)